Summary
Joint damage is a characteristic and important consequence of rheumatoid arthritis; it is usually considered to be a direct result of the inflammatory synovitis. This view implies that by treating actively the synovial inflammation subsequent joint damage will be reduced and the long-term outlook of patients with rheumatoid arthritis thus improved. However, there is relatively little clinical evidence that suppressing inflammation reduces rheumatoid joint damage. An alternative view is that the mechanisms causing inflammation and those leading to joint destruction are parallel processes related only indirectly. Considerable evidence supports such a concept.
Clinical studies show radiological progression of the disease occurs despite improvements in measures of joint inflammation and a reduction in the levels of acute phase proteins. Damage can progress in either actively inflamed hot joints or cool swollen joints. Histopathologically the features of rheumatoid synovitis are non-specific, while the radiological pattern of joint damage is very characteristic. There is evidence that lymphocytic infiltration is not a poor prognostic finding, despite it being a typical feature of inflamed joints. Experimental studies also fail to show a close correlation between inflammation and cartilage damage: this is seen in experimental arthritis, coculturein vitro systems, and the air pouch model of cartilage damage. We suggest that attempts to improve the outcome of rheumatoid arthritis should not merely concentrate on controlling inflammation but should also seek to modify the associated connective tissue changes of the disease.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
A. J. Barreit andJ. Saklatvala,Proteinases in joint disease. In;S. Ruddy,C. B. Sledge,W. N. Kelley andE. D. Harris. Eds. Textbook of Rheumatology Philadelphia: Sauders 195–209 (1981).
S. Shiozawa, K. Shiozawa andT. Fujita,Morphologic observations in the early phase of the cartilage-pannus junction. Light and electromicroscopic studies of active cellular pannus, Arthritis Rheum.26, 472–478 (1983).
D. E. Woolley, M. J. Crossley andJ. M. Evanson,Collagenase at sites of cartilage erosion in the rheumatoid joint, Arthritis Rheum.20, 1231–1239 (1977).
J. F. Woessner andD. S. Howell,Hydrolytic enzymes in cartilage, in:A. Maroudas andE. J. Holborow Eds. Studies in Joint Disease 2, London: Pitman, 106–152 (1983).
L. G. Cleland,Oxy radicals, ‘peroxide tone’ and inflammation, J. Rheumatol.11, 725–726 (1984).
R. W. Jubb,Breakdown of articular cartilage by vascular tissue. J. Path.136, 333–343 (1982).
A. J. Crisp,Mast cells in rheumatoid arthritis, J. Roy. Soc. Med.77, 450–451 (1984).
D. R. Robinson, M. B. McGuire andL. Levine,Prostglandins in the rheumatic diseases, Ann. NY. Acad. Sci.256, 318–329 (1975).
J. J. Oppenheim, T. Luger, M. B. Sztein andP. S. Steeg,Circuit of cytoteine-cell interactions that regulate immunological and inflammatory reactions. In:D. Mizuno,Z. A. Cohn,K. Takeya andN. Ishida Eds. Self defence mechanisms; role of macrophages. Holland: Elsevier Biochemicial, 127–136 (1981).
R. Luukkainen, K. Kaarela andH. Isomaki et al.,The prediction of radiological destruction during the early stages of rheumatoid arthritis, Clin. Exp. Rheumatol.1, 295–298 (1983).
A. Brook, A. Fleming andA. Corbett,Relationships of radiological change to clinical outcome in rheumatoid arthritis, Ann. Rheum. Dis.36, 274–275 (1977).
R. J. Winchester, V. Agnello andH. G. Kunkel,Gamma globulin complexes in synovial fluids of patients with rheumatoid arthritis, Clin. Exp. Immunol.6, 689–705 (1970).
T. D. Cooke, E. R. Hurd, H. E. Jasin, J. Bienenstock andM. Ziff,Identification of immunoglobulins and complement in rheumatoid articular collagenous tissue, Arthritis. Rheum.18, 541–551 (1975).
H. G. Fassbender,The pathology of rheumatic disease (trans.G. Loewi). Berlin: Springer, (1975).
H. G. Fassbender,Current understanding of rheumatoid arthritis, Inflammation8, suppl. 527–542 (1984).
V. Wright andR. Amos,Do drugs change the course of rheumatoid arthritis? Br. Med. J.280, 964–966 (1980).
B. McConkey, R. A. Crockson, A. P. Crockson andA. R. Williamson,The effects of some anti-rheumatic drugs on the acute-phase proteins in rheumatoid arthritis, Q. J. Med.42, 785–791 (1973).
L. Iannauzzi, N. Dawson, N. Zein andI. Kushner,Does any therapy slow radiographic deterioration in rheumatoid arthritis? New Engl. J. Med.309, 1023–1027 (1983).
Co-operating Clinics of the American Rheumatism Association,A controlled trial of gold salt therapy in rheumatoid arthritis, Arthritis Rheum.16, 353–358 (1974).
J. W. Sigler, G. B. Fluhm, H. Duncan, J. T. Shapp, D. L. Ensign andW. R. McRann,Gold salts in the treatment of rheumatoid arthritis. A double-blind study, Ann. Intern. Med.80, (1974).
Co-operating Clinics of the American Rheumatism Association,A controlled trial of cyclophosphamide in rheumatoid arthritis, New Engl. J. Med.282, 883–889 (1970).
T. Pullar andH. A. Capell,A rheumatological dilemma: is it possible to modify the course of rheumatoid arthritis? Can we answer the question? Ann. Rheum. Dis.44, 134–140 (1985).
D. L. Scott, K. A. Grindulis, G. R. Struthers, B. L. Coulton, A. J. Popert andP. A. Bacon,The progression of radiological changes in rheumatoid arthritis, Ann. Rheum. Dis.43, 8–17 (1984).
D. L. Scott, P. T. Dawes, P. D. Fowler, K. A. Grindulis, M. Shadforth andP. A. Bacon,Anti-rheumatic drugs and joint damage in rheumatoid arthritis, Quart. J. Med.54, 49–60 (1985).
D. L. Scott, B. L. Coulton, J. H. Chapman, P. A. Bacon andA. J. Popert,The long-term effects of treating rheumatoid arthritis, J. Roy. Coll. Phys.17, 79–85 (1983).
A. Young, M. Corbett andA. Brocook,The clinical assessment of joint infammatory activity in rheumatoid arthritis related to radiological progression, Rheumatol Rehab.19, 14–19 (1980).
N. S. Cooper, A. Soren, C. McEwen,Diagnostic specificity of synovial lesions, Human Pathol.12, 314–328 (1981).
B. Vernon Roberts,Rheumatoid joint pathology revisited. In:W. C. Dick andJ. M. H. Moll Eds. Recent Advances in Rheumatology 3. Churchill Livingstone, Edinburgh 73–96 (1983).
J. H. Kellgren, M. R. Jeffrey andJ. Ball,The epidemiology of chronic rheumatism, Vol. II. Atlas of standard radiographs of arthritis, Oxford, Blackwell (1963).
A. Larsen, K. Dale, andM. Eek,Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films, Acta Radio. (diagn)18, 481–491 (1977).
K. D. Muirden andK. W. Mills,Do lymphocytes protect the rheumatoid joint? Br. Med. J.4, 219–221 (1971).
P. E. McMaster,Pigmented villonodular synovitis with invasion of bone, J. Bone. Jt. Surg.42A, 1170–1183 (1960).
F. X. O'Sullivan, H. G. Fassbender, S. Gay andW. J. Koopman,Etiopathogenesis of the rheumatoid arthritislike disease in MRL/1 mice. I. The histomorphologic basis of joint destruction, Arthritis Rheum.28, 529–536 (1985).
V. Santer, A. Spirtana andD. A. Lowther,Carrageenin-induced arthritis: V. A Morphological study of the development of inflammation in acute arthritis, Semin. Arthritis Rheum.13, 160–168 (1983).
H. B. Fell andR. W. Jubb,The effect of synovial tissue on the breakdown of articular cartilage in organ culture, Arthritis Rheum.20, 1359–1371 (1977).
R. W. Jubb,Breakdown of articular cartilage by vascular tissue, J. Path.136, 333–334 (1982).
J. T. Dingle,Catabolin — a cartilage catabolic factor from synovium, Clinical Orthop.156, 219–223 (1981).
R. W. Jubb andJ. Saklatvala,Effect of Pig 1L-1 (catabolin) on articular chondrocytes, Br. J. Rheumatol.24 (Suppl. 1) 16–157 (1985).
J. C. W. Edwards, A. D. Sedgwick andD. A. Willoughby,The formation of a structure with the features of synovial lining by subcutaneous injection of air; an in vivotissue culture system, J. Pathol.134, 147–153 (1981).
A. D. Sedgwick, A. R. Moore, Y. M. Sin, A. Y. Alduay, B. London andD. A. Willoughby,The effect of therapeutic agents on cartilage degradation in vivo, J. Pharm. Pharmacol.36, 709–710 (1984).
F. B. DeBrito, J. D. Williams, A. R. Moore, A. Y. AlDuaij, D. L. Scott andD. A. Willoughby,Factors influencing cartilage proteoglycan loss, Br. J. Rheumatol, In press. (1985).
W. Mohr, C. J. Kirkpatrick,Die Relevanz von Tierversuchen fur die menschliche Arthrose und die Beeinflussung der tierexperimentallen Arthrose durch Medikaumente, Z. Rheumatol42, 159–170 (1983).
J. H. Herman andE. V. Hess,Non-steroidal anti-flammatory drugs and modulation of cartilaginous changes in osteoarthritis and rheumatoid arthritis. Clinical implications, Am. J. Med. 16–25 (1984).
G. P. Lewis andD. Gordon,Cytokines as potential targets for anti-rheumatic therapy: a pharmacologists view, Br. J. Rheumatol24, (Suppl 1) 29–33 (1985).
D. J. McCarty andG. F. Carrera,Intractable rheumatoid arthritis. Treatment with combined cyclophosphamide, azathioprine and hydroxychloroquine, J. Ann. Med. Med. Ass.248, 1718–1723 (1982).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Williams, J.D., Scott, D.L., DeBrito, F.B. et al. Rheumatoid inflammation and joint destruction: cause and effect or parallel phenomena?. Agents and Actions 18, 538–543 (1986). https://doi.org/10.1007/BF01964961
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01964961